Bristol-Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Capital expenditures increased by 5% from FY24 to FY25.
Current Price
$58.22
-3.91%GoodMoat Value
$98.93
69.9% undervaluedBristol-Myers Squibb Company (BMY) Social Sentiment
BMY Social Sentiment Analysis
Social media sentiment analysis for Bristol-Myers Squibb Company (BMY). Track bullish and bearish sentiment, mention volume, and BuzzScore trends from StockTwits and Reddit. Social sentiment provides a crowd-sourced view of investor confidence in BMY.
Current stock price: $58.22. Market cap: $118.56B. This page displays sentiment timelines, bullish vs bearish ratios, total mention counts, peak BuzzScore data, and source breakdowns for BMY. The sentiment data is updated regularly to reflect the latest social media activity.
Social sentiment is one of many signals to consider when evaluating a stock. High bullish sentiment combined with strong fundamentals may reinforce a buy thesis. Use GoodMoat's sentiment tracking alongside quality analysis, financial data, and valuation models to make well-informed investment decisions about Bristol-Myers Squibb Company.